Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak is a research paper published in Cancer Discovery (2020). On theSindex it has a DataRank of 1.1. It has been cited 1,627 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
1.1
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Natural Science Foundation of China
Grant: 8197103302/H16
Singapore Ministry of Health's National Medical Research Council
Grant: MOH-STaR18nov-0002
NIH NHLBI
Grant: P01HL095489
Institutional Ethics Board of Zhongnan Hospital of Wuhan University
Grant: 2020029
FWCI
111.57
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Systematic review and Meta-analysis file
Additional file 1 of Patient and health practitioner views and experiences of a cancer trial before and during COVID-19: qualitative study
Additional file 1 of Patient and health practitioner views and experiences of a cancer trial before and during COVID-19: qualitative study
Additional file 1 of Cancer surgery during COVID increased the patient mortality and the transmission risk to healthcare workers: results from a retrospective cohort study (NCT05240378)
Additional file 1 of Cancer surgery during COVID increased the patient mortality and the transmission risk to healthcare workers: results from a retrospective cohort study (NCT05240378)
Additional file 1 of Measuring symptom burden in patients with cancer during a pandemic: the MD Anderson symptom inventory for COVID-19 (MDASI-COVID)
Additional file 1 of Measuring symptom burden in patients with cancer during a pandemic: the MD Anderson symptom inventory for COVID-19 (MDASI-COVID)
Additional file 1 of Phase I/II clinical trial of efficacy and safety of EGCG oxygen nebulization inhalation in the treatment of COVID-19 pneumonia patients with cancer
Additional file 1 of Phase I/II clinical trial of efficacy and safety of EGCG oxygen nebulization inhalation in the treatment of COVID-19 pneumonia patients with cancer
Additional file 1 of Outcomes of patients with active cancers and pre-existing cardiovascular diseases infected with SARS-CoV-2
Additional file 1 of Outcomes of patients with active cancers and pre-existing cardiovascular diseases infected with SARS-CoV-2